SNY: SANOFI AVENTIS Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

Symbol	Value	Change	Percentage Change
DJIA	11,632.38	29.88	0.26%
NASDAQ	2,325.88	21.92	0.95%
S&P 500	1,282.19	5.19	0.41%

SANOFI AVENTIS

SNY

Stock price

36.01 -0.99 -2.68%

as of 04:05 PM EDT on 07/23/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

36.1369 0.1269 0.35%

as of 04:12 PM EDT on 07/23/08

Analyst Consensus
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

SANOFI AVENTIS Profile

Sanofi-Aventis helps docs treat their sneezy patients without making them grumpy or dopey. The maker of allergy medicine Allegra specializes in six therapeutic categories: internal medicine (including allergies), cardiovascular disease, thrombosis (blood clots), central nervous system disorders, cancer, and metabolic conditions. Its top sellers include blood thinners Lovenox and Plavix (which it markets with Bristol Myers Squibb), cancer drugs Taxotere and Eloxatine, insulin brand Lantus, and insomnia treatment Ambien. It also one of the largest makers of vaccines through its Sanofi Pasteur subsidiary. The company is Europe's largest pharmaceutical company.

Gerard Le Fur: CEO

174 avenue de France

75013 Paris, France

http://www.sanofi-aventis.com

Phone: +33-1-53-77-40-00

Fax: +33-1-53-77-43-03

Sector: Healthcare Industry: Drugs

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$43,019,000,000	10.5%	$8,369,000,000	99,495

Key Executives: SNY

Name	Title	Officer Since
Gerard Le Fur	CEO	5/1/06
Laurence Debroux	CFO	-
Karen Linehan	General Counsel	-
Belen Garijo	Senior VP, Divisional	-
Jurgen Dormann	—	-
Christian Mulliez	Director	6/1/04
Gérard Van Kemmel	—	-
Jean-Marc Bruel	Director	8/1/04

View All Key Executives

Belen Garijo has a degree in medicine, majoring in clinical pharmacology. Her career in the pharmaceutical industry began at Abbott, where she was Medical Director of the Spanish subsidiary before being appointed Director of International Medical Affairs at Abbott's United States headquarters in Illinois. In 1996, she joined Rhone-Poulenc Rorer in Spain as Head of the Oncology Business Unit. She was subsequently responsible for Aventis' global... View Full Profile

Belen Garijo

Belen Garijo has a degree in medicine, majoring in clinical pharmacology. Her career in the pharmaceutical industry began at Abbott, where she was Medical Director of the Spanish subsidiary before being appointed Director of International Medical Affairs at Abbott's United States headquarters in Illinois. In 1996, she joined Rhone-Poulenc Rorer in Spain as Head of the Oncology Business Unit. She was subsequently responsible for Aventis' global... View Full Profile

Jurgen Dormann

Christian Mulliez, Vice President, General Manager Administration and Finance of L'Oreal. Chairman of the Board of Directors of Regefi. Director of DG 17 Invest and L'Oreal USA Inc. and The Body Shop International (United Kingdom).... View Full Profile

Christian Mulliez

Christian Mulliez, Vice President, General Manager Administration and Finance of L'Oreal. Chairman of the Board of Directors of Regefi. Director of DG 17 Invest and L'Oreal USA Inc. and The Body Shop International (United Kingdom).... View Full Profile

Gérard Van Kemmel

Jean-Marc Bruel, Chairman of Firmenich (Switzerland). Director of L'Institut Curie.... View Full Profile

Jean-Marc Bruel

Igor Landau, Director of HSBC France and INSEAD. Member of the Supervisory Boards of Allianz AG (Germany) and Adidas-Salomon (Germany).... View Full Profile

Igor Landau

Klaus Pohle, Vice-Chairman of the Supervisory Board, Chairman of the Audit Committee and Member of Nomination and Corporate Governance Committee of Hypo Real Estate Holding AG, Munich (Germany). Director of Coty Inc., New York. Chairman of the Audit Committee of Coty Inc., New York. Member of the Supervisory Board and Chairman of the Audit Committee of DWS Investment GmbH, Frankfurt (Germany).... View Full Profile

Klaus Pohle

Pierre Chancel, a pharmacist, is a graduate of the Institut de Pharmacie Industrielle in Paris. At Rhone-Poulenc, from 1994 to 1996, he was Marketing Director for Theraplix. From 1997 to 1999, Mr. Chancel served as Business Unit Manager in charge of products in the central nervous system, rheumatology and hormone replacement therapy fields. From 2003, he served as Managing Director of Aventis Operations in the United Kingdom and Ireland. Before... View Full Profile

Pierre Chancel

Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d'Etudes Politiques in Paris. From 1989 to 1994, he worked in the Mergers & Acquisitions department of Banque de l'Union Europeenne. He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently, he held various posts within the Group, including Chief Financial Officer (Asia) for Sanofi-Syntheeabo in 1999 and Attache to the Chairman,... View Full Profile

Olivier Charmeil

Marc Cluzel is a Doctor of Medicine and a Doctor of Science. He began his career in hospital medicine before carrying out research at Johns Hopkins University (Baltimore) and Guy's Hospital (London). In 1991, he joined Sanofi Recherche as a clinical pharmacologist, and was then appointed successively as Senior Project Director in 1993, Vice President, Research Projects Management in 1996 (retaining this position after the 1999 merger with... View Full Profile

Marc Cluzel

Laurence Debroux is a graduate of HEC (Ecole des Hautes Etudes Commerciales). She began her career with Merrill Lynch in London, and then worked in the Finance Department of the Elf Aquitaine Group from 1993 to 1996. She joined the Sanofi Group as Corporate Treasurer in 1996, and was appointed Head of Financing/Treasury in 1997. From 2000 to 2004, she served as Head of Strategic Planning, before becoming Deputy Chief Financial Officer. She was... View Full Profile

Laurence Debroux

Philippe Fauchet is a graduate of HEC (Ecole des Hautes Etudes Commerciales), and also holds a law degree. After two years with a subsidiary of Renault, Philippe Fauchet joined Roussel Uclaf in 1984, and, held a number of posts in France, Japan and Korea, before becoming Vice President of the Asia-Pacific region for Hoechst Marion Roussel. He joined Sanofi in 1996, and headed up the Eastern Europe region from 1997, before becoming Vice President,... View Full Profile

Philippe Fauchet

Gregory Irace holds a B.S. in accounting from Albany State University (New York). He began his career at Price Waterhouse in 1980 and received his CPA in 1982. He spent 11 years at Price Waterhouse becoming a Senior Audit Manager in 1988, and a Senior Manager in the Corporate Finance Department in 1989. In 1991 he joined Sterling Winthrop Inc. as Regional Controller and in 1993 he became Director of Financial Planning and Analysis for Sanofi... View Full Profile

Gregory Irace

Michel Labie is a graduate of the Taipei Ecole Normale de Langues (Taiwan), holds a diploma in Chinese from the Institut National des Langues et Civilisations Orientales (INALCO) and a bachelor degree (maitrise) in Chinese Traditional Pharmacopoeia. He began his career with Sanofi in 1981, opening the company's Beijing bureau in China in 1982. In 1995, he moved to France as head of International Professional Relations, before becoming head of... View Full Profile

Michel Labie

Jean-Michel Levy, a graduate of HEC (Ecole des Hautes Etudes Commerciales), joined the Midy Group in 1969. He held various positions in Marketing and Business Development, first at Clin Midy and then at Sanofi. Since 1989, he has worked in the Finance and Strategy Departments in a variety of roles connected with acquisitions and strategy/planning. He was appointed to his current position in January 2007.... View Full Profile

Jean- Michel Levy

Karen Linehan graduated from Georgetown University with bachelor of arts and juris doctorate degrees. Prior to practicing law, Ms. Linehan served on the congressional staff of the Speaker of the U.S. House of Representatives from September 1977 to August 1986. Until December 1990, she was an Associate in a mid-size law firm in New York, New York. In January 1991, she joined Sanofi as Assistant General Counsel of its US subsidiary. In July 1996,... View Full Profile

Live Updates:

Ticker

Dynamic view of the market

SANOFI AVENTIS

SNY

Stock price

Extended Hours

Analyst Consensus

SANOFI AVENTIS Profile

Key Executives: SNY